ENDRA Life Sciences statement lists ASP Isotopes as 10% owner
NDRA•ENDRA Life Sciences' Form 3 lists ASP Isotopes, through LHE LNG Holdings, as a 10% owner with 66,846 common shares, 511,541 pre-funded warrants and warrants for 1,156,774 shares.
1. Ownership filing
The statement lists 511,541 pre-funded warrants exercisable at $0.0001 with no expiration. It also lists warrants for 1,156,774 shares at $6.57, expiring May 27, 2031, with exercisability tied to stockholder approval; the event date is Oct. 1, 2026, and the filing was signed Oct. 8.
